Themis Medicare enters into a License and Supply Agreement with Novartis India

13 Apr 2013 Evaluate

Themis Medicare (Themis) has entered into a License and Supply Agreement with Novartis India (Novartis) on March 26, 2013. As per agreement, Themis has agreed to manufacture and supply Diclofenac topical gel formulated using unique TPM transdermal drugs delivery system in finished dosage pharmaceutical form on certain commercial terms and conditions. Novartis has agreed to purchase the same.

Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab., Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.

Themis Medicare Share Price

89.15 -2.70 (-2.94%)
19-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.95
Dr. Reddys Lab 1168.25
Cipla 1386.00
Zydus Lifesciences 879.00
Lupin 2178.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×